Pain medicine Archives - Page 2 of 3

Videos

Clinical Case: 45-year-old male with acute back pain – The role of orphenadrine

In this Quick Case, Pain Physician A/Prof Marc Russo presents the case of a 45-year-old male with acute pain, describes treatment options, clinical outcomes, and provides some take home messages.

Videos

Celecoxib update

In this Product Explainer, Clinical Pharmacist Joyce McSwan explains the role of COX-2 inhibitor celecoxib, and provides an update on its downscheduling.

Videos

Orphenadrine for muscle spasm

In this Product Explainer, Pain Medicine Physician A/Prof Marc Russo explains the role of orphenadrine in the management of muscle spasm.

Clinical Articles

Evidence doesn’t support spinal cord stimulators for chronic back pain – and they could cause harm

Despite their long history, rigorous experimental research to test the effectiveness of spinal cord stimulators has only been conducted this century. The findings don’t support their use for treating chronic pain...

Clinical Articles

What is the PanaNatra line of painkillers and can herbal products effectively relieve pain?

In an era where chronic pain affects millions worldwide, the search for effective and safe pain relief has never been greater...

Clinical Articles

Understanding that chronic back pain originates from within the brain could lead to quicker recovery, a new study finds

Most people with chronic back pain naturally think their pain is caused by injuries or other problems in the body such as arthritis or bulging disks...

Clinical Articles

Mastering migraine management in a changing treatment landscape

What you need to know about CGRP targeted therapies, from changes in PBS criteria to precautions in different populations...

Podcasts

Chronic back pain – Practical management advice

What are yellow flags for back pain?, knowing these and practising mindful therapeutics can help mitigate the risk of progression of acute pain to chronic pain, and how chronic pain is a disease in its own right

Videos

The role of tapentadol an atypical opioid in the management of severe pain

In this Product Explainer, Pain Management Physician Dr Clayton Thomas explains the role of tapentadol, an atypical opioid, when clinically indicated and key considerations for GPs when choosing an opioid as part of a multi-modal, multi-disciplinary approach to managing severe pain (4 mins).

Monographs

Active Ingredient Prescribing: What GPs need to know

This article outlines the key changes associated with Active Ingredient Prescribing, the reasons for its introduction and the practicalities in relation to its application in the primary care setting.

Podcasts

Non-drug pain management

Acute pain becomes chronic pain somewhere between the three and six month mark

Clinical Articles

Paracetamol vs ibuprofen for young children

Pain medicine

Clinical Case: 45-year-old male with acute back pain – The role of orphenadrine

In this Quick Case, Pain Physician A/Prof Marc Russo presents the case of a 45-year-old male with acute pain, describes treatment options, clinical outcomes, and provides some take home messages.

Celecoxib update

In this Product Explainer, Clinical Pharmacist Joyce McSwan explains the role of COX-2 inhibitor celecoxib, and provides an update on its downscheduling.

Orphenadrine for muscle spasm

In this Product Explainer, Pain Medicine Physician A/Prof Marc Russo explains the role of orphenadrine in the management of muscle spasm.

Evidence doesn’t support spinal cord stimulators for chronic back pain – and they could cause harm

Despite their long history, rigorous experimental research to test the effectiveness of spinal cord stimulators has only been conducted this century. The findings don’t support their use for treating chronic pain...

What is the PanaNatra line of painkillers and can herbal products effectively relieve pain?

In an era where chronic pain affects millions worldwide, the search for effective and safe pain relief has never been greater...

Understanding that chronic back pain originates from within the brain could lead to quicker recovery, a new study finds

Most people with chronic back pain naturally think their pain is caused by injuries or other problems in the body such as arthritis or bulging disks...

Mastering migraine management in a changing treatment landscape

What you need to know about CGRP targeted therapies, from changes in PBS criteria to precautions in different populations...

Chronic back pain – Practical management advice

What are yellow flags for back pain?, knowing these and practising mindful therapeutics can help mitigate the risk of progression of acute pain to chronic pain, and how chronic pain is a disease in its own right

The role of tapentadol an atypical opioid in the management of severe pain

In this Product Explainer, Pain Management Physician Dr Clayton Thomas explains the role of tapentadol, an atypical opioid, when clinically indicated and key considerations for GPs when choosing an opioid as part of a multi-modal, multi-disciplinary approach to managing severe pain (4 mins).

Active Ingredient Prescribing: What GPs need to know

This article outlines the key changes associated with Active Ingredient Prescribing, the reasons for its introduction and the practicalities in relation to its application in the primary care setting.

Non-drug pain management

Acute pain becomes chronic pain somewhere between the three and six month mark

Paracetamol vs ibuprofen for young children

Get the app

Site

Company

Connect

Legal

Healthed

Upcoming Healthed Webcast

Rosacea – Smarter diagnosis & state-of-the-art care

Tuesday 14th April, 7pm - 9pm AEST

Speaker

Dr Belinda Welsh

Dermatologist; Senior Vice President, Australasian Society of Cosmetic Dermatologists

Join Dr Belinda Welsh, who will also present a practical framework for the effective management of rosacea, a condition that can be controlled by not cured.

Pain medicine

In this Quick Case, Pain Physician A/Prof Marc Russo presents the case of a 45-year-old male with acute pain, describes treatment options, clinical outcomes, and provides some take home messages.

In this Product Explainer, Clinical Pharmacist Joyce McSwan explains the role of COX-2 inhibitor celecoxib, and provides an update on its downscheduling.

In this Product Explainer, Pain Medicine Physician A/Prof Marc Russo explains the role of orphenadrine in the management of muscle spasm.

Despite their long history, rigorous experimental research to test the effectiveness of spinal cord stimulators has only been conducted this century. The findings don’t support their use for treating chronic pain...

In an era where chronic pain affects millions worldwide, the search for effective and safe pain relief has never been greater...

Most people with chronic back pain naturally think their pain is caused by injuries or other problems in the body such as arthritis or bulging disks...

What you need to know about CGRP targeted therapies, from changes in PBS criteria to precautions in different populations...

What are yellow flags for back pain?, knowing these and practising mindful therapeutics can help mitigate the risk of progression of acute pain to chronic pain, and how chronic pain is a disease in its own right

In this Product Explainer, Pain Management Physician Dr Clayton Thomas explains the role of tapentadol, an atypical opioid, when clinically indicated and key considerations for GPs when choosing an opioid as part of a multi-modal, multi-disciplinary approach to managing severe pain (4 mins).

This article outlines the key changes associated with Active Ingredient Prescribing, the reasons for its introduction and the practicalities in relation to its application in the primary care setting.

Acute pain becomes chronic pain somewhere between the three and six month mark

Save time on registrations, track CPD, listen to full podcasts... sign in to your Healthed account now

Don't have an existing account? Sign up today

Extra Details

Healthed

Upcoming Healthed Webcast

Rosacea – Smarter diagnosis & state-of-the-art care

Tuesday 14th April, 7pm - 9pm AEST

Speaker

Dr Belinda Welsh

Dermatologist; Senior Vice President, Australasian Society of Cosmetic Dermatologists

Join Dr Belinda Welsh, who will also present a practical framework for the effective management of rosacea, a condition that can be controlled by not cured.